{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:23:56Z","timestamp":1786987436533,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.coph.2016.07.011","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T20:33:26Z","timestamp":1469824406000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Co-morbidity of PTSD and immune system dysfunction: opportunities for treatment"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-9161","authenticated-orcid":false,"given":"Gretchen N","family":"Neigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariya F","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2016.07.011_bib0270","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the National Comorbidity Survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0275","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archpsyc.55.7.626","article-title":"Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma","volume":"55","author":"Breslau","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S2045796014000110","article-title":"Risk of post-traumatic stress disorder following traumatic events in a community sample","volume":"24","author":"White","year":"2015","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.coph.2016.07.011_bib0285","first-page":"13","article-title":"Neurobiology of posttraumatic stress disorder","volume":"14","author":"Heim","year":"2009","journal-title":"CNS Spectr"},{"key":"10.1016\/j.coph.2016.07.011_bib0290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbi.2010.10.003","article-title":"A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities","volume":"25","author":"Pace","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2016.07.011_bib0295","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1196\/annals.1314.011","article-title":"Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies","volume":"1032","author":"Boscarino","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl. 2","key":"10.1016\/j.coph.2016.07.011_bib0300","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.3949\/ccjm.76.s2.12","article-title":"Is posttraumatic stress disorder related to development of heart disease? An update","volume":"76","author":"Kubzansky","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.coph.2016.07.011_bib0305","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1586\/ern.12.77","article-title":"Post-traumatic stress disorder as a comorbidity: impact on disease outcomes","volume":"12","author":"Cavalcanti-Ribeiro","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.coph.2016.07.011_sbref0310","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.biopsych.2014.06.015","article-title":"Elevated risk for autoimmune disorders in iraq and afghanistan veterans with posttraumatic stress disorder","volume":"77","author":"O\u2019Donovan","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0315","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000356552","article-title":"Neuroimmunoendocrine interactions in post-traumatic stress disorder: focus on long-term implications of childhood maltreatment","volume":"21","author":"Wieck","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.coph.2016.07.011_bib0320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbi.2012.08.015","article-title":"Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions","volume":"30","author":"van Zuiden","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2016.07.011_bib0325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuint.2007.06.037","article-title":"Neurohormonal\u2013cytokine interactions: implications for inflammation, common human diseases and well-being","volume":"52","author":"Elenkov","year":"2008","journal-title":"Neurochem Int"},{"issue":"Suppl. 2","key":"10.1016\/j.coph.2016.07.011_bib0330","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar4687","article-title":"Circadian rhythms in rheumatology\u2014a glucocorticoid perspective","volume":"16","author":"Spies","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coph.2016.07.011_bib0335","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1038\/tp.2014.3","article-title":"Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder","volume":"4","author":"Labont\u00e9","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_sbref0340","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neubiorev.2016.02.005","article-title":"Genetics of glucocorticoid regulation and posttraumatic stress disorder\u2014what do we know?","volume":"63","author":"Castro-Vale","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.coph.2016.07.011_sbref0345","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","article-title":"Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression","volume":"2","author":"Passos","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0350","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jamapsychiatry.2013.4374","article-title":"Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk","volume":"71","author":"Eraly","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0355","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.psyneuen.2014.07.010","article-title":"Cytokine production as a putative biological mechanism underlying stress sensitization in high combat exposed soldiers","volume":"51","author":"Smid","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2016.07.011_bib0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.psychres.2015.05.036","article-title":"Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders","volume":"229","author":"Furtado","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.coph.2016.07.011_bib0365","doi-asserted-by":"crossref","first-page":"e76146","DOI":"10.1371\/journal.pone.0076146","article-title":"Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model","volume":"8","author":"Wilson","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2016.07.011_bib0370","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.euroneuro.2014.11.012","article-title":"Early post-stressor intervention with minocycline, a second-generation tetracycline, attenuates post-traumatic stress response in an animal model of PTSD","volume":"25","author":"Levkovitz","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.coph.2016.07.011_sbref0375","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/mp.2015.9","article-title":"Gene networks specific for innate immunity define post-traumatic stress disorder","volume":"20","author":"Breen","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0380","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.psyneuen.2016.01.024","article-title":"PTSD is associated with an increase in aged T cell phenotypes in adults living in Detroit","volume":"67","author":"Aiello","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2016.07.011_bib0385","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.psyneuen.2014.09.014","article-title":"Pre-deployment differences in glucocorticoid sensitivity of leukocytes in soldiers developing symptoms of PTSD, depression or fatigue persist after return from military deployment","volume":"51","author":"van Zuiden","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2016.07.011_bib0390","doi-asserted-by":"crossref","first-page":"e94075","DOI":"10.1371\/journal.pone.0094075","article-title":"Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder","volume":"9","author":"Zhou","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2016.07.011_bib0395","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11481-015-9643-8","article-title":"Evidence for epigenetic regulation of pro-inflammatory cytokines, interleukin-12 and interferon gamma, in peripheral blood mononuclear cells from PTSD patients","volume":"11","author":"Bam","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.coph.2016.07.011_bib0400","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1710-1492-10-43","article-title":"Patients with posttraumatic stress disorder exhibit an altered phenotype of regulatory T cells","volume":"10","author":"Jergovi\u0107","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.coph.2016.07.011_bib0405","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and\u2014yet\u2014unanswered questions","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coph.2016.07.011_bib0410","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2015.11.006","article-title":"Ageing and the telomere connection: an intimate relationship with inflammation","volume":"25","author":"Zhang","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.coph.2016.07.011_bib0415","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.autrev.2010.04.004","article-title":"The telomere\/telomerase system in autoimmune and systemic immune-mediated diseases","volume":"9","author":"Georgin-Lavialle","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coph.2016.07.011_sbref0420","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jagp.2015.04.001","article-title":"Is post-traumatic stress disorder associated with premature senescence? A review of the literature","volume":"23","author":"Lohr","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0425","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/npp.2012.147","article-title":"PACAP and the PAC1 receptor in post-traumatic stress disorder","volume":"38","author":"Dias","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2016.07.011_bib0430","first-page":"16","article-title":"The epidemiology of posttraumatic stress disorder: what is the extent of the problem?","volume":"62","author":"NB","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0435","doi-asserted-by":"crossref","first-page":"263","DOI":"10.31887\/DCNS.2011.13.2\/jsherin","article-title":"Post-traumatic stress disorder: the neurobiological impact of psychological trauma","volume":"13","author":"Sherin","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.coph.2016.07.011_bib0440","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/npp.2012.191","article-title":"Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline \u201cpredictors\u201d and longitudinal \u201ctargets\u201d","volume":"38","author":"Cattaneo","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2016.07.011_bib0445","first-page":"393251","article-title":"A pilot study of mifepristone in combat-related PTSD","volume":"2012","author":"Golier","year":"2012","journal-title":"Depress Res Treat"},{"key":"10.1016\/j.coph.2016.07.011_bib0450","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.psyneuen.2015.11.001","article-title":"A randomized, double-blind, placebo-controlled, crossover trial of mifepristone in Gulf War veterans with chronic multisymptom illness","volume":"64","author":"Golier","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2016.07.011_bib0455","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nchembio.1699","article-title":"Selective inhibitors of the FK506-binding protein 51 by induced fit","volume":"11","author":"Gaali","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.coph.2016.07.011_bib0460","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nlm.2013.08.014","article-title":"Systemic inhibition of mTOR kinase via rapamycin disrupts consolidation and reconsolidation of auditory fear memory","volume":"112","author":"Mac Callum","year":"2014","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.coph.2016.07.011_bib0465","first-page":"2134","article-title":"Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies","volume":"54","author":"Cavalli","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.coph.2016.07.011_bib0470","doi-asserted-by":"crossref","DOI":"10.1002\/art.39700","article-title":"The efficacy and safety of clazakizumab, an anti-interleukin-6 monoclonal antibody, in a phase 2b study of adults with active psoriatic arthritis","author":"Mease","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.coph.2016.07.011_bib0475","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2009.05366.x","article-title":"Anti-TNF therapy restores the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"1193","author":"Atzeni","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.coph.2016.07.011_bib0480","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm.4010","article-title":"Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice","volume":"22","author":"Chang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2016.07.011_bib0485","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2012.10.002","article-title":"A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?","volume":"67","author":"Walker","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2016.07.011_bib0490","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/art.27304","article-title":"Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors","volume":"62","author":"Sacre","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coph.2016.07.011_bib0495","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1745-6215-15-37","article-title":"Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial","volume":"15","author":"Cambron","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.coph.2016.07.011_bib0500","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000321634","article-title":"The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"18","author":"Taler","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.coph.2016.07.011_bib0505","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/jnnp.2007.139345","article-title":"Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study","volume":"79","author":"Mostert","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0510","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.pra.0000452561.98286.1e","article-title":"Prazosin in the treatment of PTSD","volume":"20","author":"Green","year":"2014","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.coph.2016.07.011_bib0515","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000067178","article-title":"Lateralization and catecholaminergic neuroimmunomodulation: prazosin, an alpha1\/alpha2-adrenergic receptor antagonist, suppresses interleukin-1 and increases interleukin-10 production induced by lipopolysaccharides","volume":"10","author":"Dong","year":"2002","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.coph.2016.07.011_bib0520","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000343762","article-title":"Novel anti-inflammatory effects of doxazosin in rodent models of inflammation","volume":"91","author":"Tung","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/j.coph.2016.07.011_bib0525","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.coph.2016.07.011_bib0530","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.drudis.2014.08.017","article-title":"Ketamine: repurposing and redefining a multifaceted drug","volume":"19","author":"Potter","year":"2014","journal-title":"Drug Discov Today"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216300716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216300716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T06:43:28Z","timestamp":1656917008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489216300716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":53,"alternative-id":["S1471489216300716"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2016.07.011","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-morbidity of PTSD and immune system dysfunction: opportunities for treatment","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2016.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}